Universidad de León
Ponferrada, León, 24400, Spain
NCT Number: NCT06905639
Study Type: Clinical Trial
Primary Purpose: To determine whether physical exercise improves or prevents lymphedema in breast cancer patients.
Description of the Participant Population/Main Condition: The study is aimed at women who have been diagnosed with breast cancer and have experienced post-treatment lymphedema or are at risk of developing it. The target population includes adults aged 18 to 70 who have been diagnosed with this condition following their breast cancer treatment.
Main Research Questions:
Does physical exercise improve or prevent lymphedema in women with breast cancer? What are the effects of physical exercise on the reduction of arm volume affected by lymphedema? What are the effects of physical exercise on the reduction of perceived disability in the arm affected by lymphedema?
Hypothesis:
Physical exercise intervention significantly reduces lymphedema symptoms, such as arm volume. Physical exercise prevents the progression of lymphedema in women with breast cancer.
Comparison Group: Researchers will compare results between the experimental group (which will undergo physical exercise) and the control group (which will receive no intervention) to determine if physical exercise has a significant impact on the improvement or prevention of lymphedema.
Participant Tasks:
The experimental group will follow a supervised physical exercise program for a specific period. The control group will receive no intervention and will be monitored with standard follow-up care without exercise. Participants will be evaluated before and after the study period to measure the progression of lymphedema, including arm volume measurement and surface skin temperature using thermography.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ponferrada, León, 24400, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A supervised physical exercise intervention was carried out, specifically designed to improve post-breast cancer lymphedema. The program will include a combination of strength exercises and aerobic exercises, with the aim of improving mobility, reducing inflammation, and increasing muscle strength in the arm affected by lymphedema
Time frame: 10 weeks
The perimeter of the arm affected by lymphedema will be measured to assess the reduction in lymphedema volume in the participants. This measurement will be taken before and after the intervention to compare changes and determine the impact of physical exercise on inflammation and the size of the affected arm
Time frame: 10 weeks
Thermography will be used to assess the temperature distribution in the arm affected by lymphedema. A thermal image will be taken before and after the intervention to observe changes in inflammation and circulation in the affected area, allowing the evaluation of whether physical exercise has an effect on the reduction of temperature associated with lymphedema
Time frame: 10 weeks
The Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire will be used to assess the functionality of the arm in the participants. This questionnaire measures limitations in daily activities related to the arm affected by lymphedema. It will be administered before and after the intervention to assess changes in mobility and functional capacity following physical exercise. In the DASH questionnaire, higher scores indicate greater disability, while lower scores indicate less disability
Time frame: 10 weeks
Bicipital and tricipital skinfold measurements will be taken to assess the body composition and body fat percentage of the participants. These measurements will help analyze the impact of physical exercise on the reduction of body fat and potential improvements in muscle mass, especially in the area affected by lymphedema. The skinfolds will be measured in millimeters (mm), and body fat percentage will be measured in percentage (%).
Time frame: 10 weeks
The RS-14 Questionnaire (Resilience Scale for Adults) will be used to assess resilience in the participants. This questionnaire will allow us to observe whether the physical exercise intervention has an effect on the participants. In the RS-14 questionnaire, higher scores indicate greater resilience, while lower scores indicate lower resilience.
Maximum and Minimum Scores: The questionnaire consists of 14 items, each rated on a Likert scale from 1 to 7, where:
1 means "strongly disagree" 7 means "strongly agree"
The scores are summed to obtain a total score, with a scoring range of 14 to 98:
Minimum score: 14 (low resilience) Maximum score: 98 (high resilience)
Time frame: 10 weeks
The Trait Meta-Mood Scale (TMMS-24) questionnaire will measure the level of emotional intelligence in the participants, including the perception, understanding, and regulation of emotions. It will be administered before and after the intervention to evaluate whether physical exercise influences the improvement of emotional intelligence in patients with lymphedema.
Scores: The TMMS-24 questionnaire consists of 24 items, distributed across three dimensions:
Emotional Perception Emotional Understanding Emotional Regulation
Each item is rated on a Likert scale from 1 to 5, where:
1 means "strongly disagree" 5 means "strongly agree"
Scores are summed within each dimension, and a total emotional intelligence score is obtained, with score ranges indicating different levels of emotional ability:
Low score: Indicates lower capacity in emotional perception, understanding, and regulation.
High score: Indicates greater capacity in these areas.
Time frame: 10 weeks
The MOS Social Support Survey (MOS-SSS) questionnaire will be used to measure the level of social support received by the participants. This questionnaire will help identify how social support may influence the response to physical exercise.
Scores: The MOS-SSS questionnaire consists of several questions related to different dimensions of social support, such as emotional, instrumental, and relational support. Responses are rated on a Likert scale from 1 to 5, where:
1 means "None" (indicating a very low level of social support) 5 means "A lot" (indicating a very high level of social support) Scores are summed to obtain a total score, and in this case, higher scores indicate a higher level of social support, while lower scores indicate a lower level of social support.
Time frame: 10 weeks
Changes in the participants' weight will be evaluated throughout the study. Weight will be measured in kilograms (kg), and these measurements will allow us to observe whether the physical exercise intervention has an effect on weight loss or gain in the participants. Additionally, the Body Mass Index (BMI) will be calculated for each participant, which is obtained by dividing weight (in kilograms) by height squared (in meters). The height of the participants will also be measured in meters (m) to assess changes in their overall body composition.
Time frame: 10 weeks
Body water percentages will be measured for each participant using validated measuring devices, such as a Tanita. This will provide a more complete picture of changes in body composition, as body water is a key indicator of hydration and overall body balance. With these measurements, it will be possible to identify variations in the distribution of fluids and other important components of the body over time.
Time frame: 10 weeks
Body fat percentages will be measured for each participant using validated measuring devices, such as a Tanita. This will provide a more complete picture of changes in body composition, as body water is a key indicator of hydration and overall body balance. With these measurements, it will be possible to identify variations in the distribution of fluids and other important components of the body over time.
Marta Arias Crespo
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01550250
Breast Diseases, Breast Neoplasms
Calgary, Alberta, Canada
View Trial DetailsNCT01279018
Breast Diseases, Breast Neoplasms
View Trial DetailsNCT00188604
Breast Diseases, Breast Neoplasms
Toronto, Ontario, Canada
View Trial DetailsNCT04228991
Breast Diseases, Breast Neoplasms
Calgary, Alberta, Canada
View Trial Details